Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

NRX Pharmaceuticals (NRXP) Profit After Tax (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Profit After Tax for 2 consecutive years, with $360000.0 as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 103.97% to $360000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$28.6 million through Dec 2025, down 13.92% year-over-year, with the annual reading at -$28.6 million for FY2025, 13.91% down from the prior year.
  • Profit After Tax for Q4 2025 was $360000.0 at NRX Pharmaceuticals, up from -$5.9 million in the prior quarter.
  • The five-year high for Profit After Tax was $360000.0 in Q4 2025, with the low at -$17.6 million in Q2 2025.